Search for human, veterinary and plants medications, drugs, supplements, herbal, nutritional and homoeopathic products;

prescription and over-the-counter medicines and medical devices;

beauty products and cosmetics, natural remedies and other pharmaceutical products

Stamibio Beauty - Dermocosmetic Anti-aging cream

Marketed by: GUNA
Active ingredient: ROE EXTRACT, BIO-PLEX RNA, OLIGOELEMENTI, JOJOBA OIL, RHODIOLA ROSEA, GINSENG, GUARANÀ, OENOTHERA BIENNIS, Coenzyme Q10 (Ubiquinone)
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Lotion Dermocosmetic Restructuring Lotion

Marketed by: GUNA
Active ingredient: ROE EXTRACT, GINGKO BILOBA, SALVIA OFFICINALIS, VITAMIN E
Other information: Lotion

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Calmderm Fluid dermocosmetic cream

Marketed by: GUNA
Active ingredient: ROE EXTRACT, GLYCYRRHETINIC ACID , VITAMIN E , PROVITAMIN D , BOSWELLIA SERRATA, LECITHIN, ZANTHALENE, CALMING AGENT (SYMSITIVE)
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Derm Skin-protecting dermocosmetic cream

Marketed by: GUNA
Active ingredient: Roe extract, Glycyrrhetinic acid, Vitamin E (Tocopheryl acetate), 7-Dehydrocholesterol ,Boswellia serrata, Zanthoxylum alatum
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Serum Dermocosmetic serum

Marketed by: GUNA
Active ingredient: ROE EXTRACT, HIGH MOLECULAR WEIGHT HYALURONIC ACID, INOSITOL, HOP EXTRACT, COCOA EXTRACT, GINSENG, GUARANÀ,LOTUS EXTRACT, HYDROLYZED DNA AND RNA, MACA EXTRACT, TRACE ELEMENTS, ANTI-SPOT COMPLEX
Other information: Serum

Available in: Italy
Language: English
Source: myHealthbox

Dutrebis 150 mg film-coated tablets lamivudine, raltegravir

Marketed by: Merck Sharp & Dohme Limited
Active ingredient: Lamivudine, raltegravir potassium
Other information: Film-coated tablets - 150 mg of lamivudine and 300 mg of raltegravir

Available in: European Union
Language: English
Source: myHealthbox

Laxido Paediatric Plain 6.9 g, powder for oral solution

Marketed by: Galen Limited
Active ingredient: Macrogol 3350, Sodium Chloride, Sodium Hydrogen Carbonate, Potassium Chloride
Other information: Powder for oral solution. - 6.563 g, 175.4 mg, 89.3 mg, 25.1 mg

Available in: United Kingdom
Language: English
Source: myHealthbox

Raloxifene hydrochloride 60 mg Film-Coated Tablets

Marketed by: Pharmathen S.A
Active ingredient: Raloxifene hydrochloride
Other information: Film-coated Tablet - 60 mg

Available in: United Kingdom
Language: English
Source: myHealthbox

Desogestrel 75 microgram Film-coated Tablets

Marketed by: Laboratorios León Farma, S.A.
Active ingredient: Desogestrel
Other information: Film-coated Tablet - 75 mg

Available in: United Kingdom
Language: English
Source: myHealthbox

Rasilez 300 mg film-coated tablets

Marketed by: Novartis Europharm Ltd.
Active ingredient: aliskiren
Other information: Film-coated tablet - 300 mg

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez 150 mg film-coated tablets

Marketed by: Novartis Europharm Ltd.
Active ingredient: aliskiren
Other information: Film-coated tablet - 150 mg

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Pneumovax 23 solution for injection in pre-filled syringe

Marketed by: Sanofi Pasteur MSD Ltd
Active ingredient: Pneumococcal Polysaccharide
Other information: Solution for Injection - 0.5 ml dose of vaccine contains 25 micrograms of 23 pneumococcal polysaccharide serotypes. See SPC for further informations.

Available in: Ireland
Language: English
Source: myHealthbox

Symbicort Turbohaler, 400 micrograms/12 micrograms/inhalation, inhalation powder

Marketed by: IMED Healthcare Ltd.
Active ingredient: Budesonide, formoterol fumarate dihydrate
Other information: Inhalation powder - Each delivered dose contains: budesonide 320 micrograms/inhalation and formoterol fumarate dihydrate 9 micrograms/inhalation

Available in: Ireland
Language: English
Source: myHealthbox

Teicoplanin 400 mg Powder and Solvent for Solution for injection/infusion or oral solution

Marketed by: Noridem Enterprises Ltd
Active ingredient: Teicoplanin
Other information: Powder and solvent for solution - 400 mg

Available in: Ireland
Language: English
Source: myHealthbox

Xalacom 50 micrograms/ml + 5 mg/ml eye drops, solution

Marketed by: PCO Manufacturing
Active ingredient: Latanoprost, timolol maleate
Other information: Eye drops solution - 1 ml solution contains latanoprost 50 micrograms and timolol maleate 6.8 mg

Available in: Ireland
Language: English
Source: myHealthbox

Urostemol capsules

Marketed by: Omega Pharma Ltd
Active ingredient: Pumpkin seed, crushed, pumpkin seed oil
Other information: Capsule, hard. - 400 mg, 340 mg

Available in: United Kingdom
Language: English
Source: myHealthbox

Urostemol femina capsules

Marketed by: Omega Pharma Ltd
Active ingredient: Pumpkin seed oil, dry extract of Fragrant Sumach bark, dry extract of Hop strobile
Other information: Capsule, hard. - 227.3 mg, 56 mg, 18 mg

Available in: United Kingdom
Language: English
Source: myHealthbox

9-12-2015

Orphan designation: Imatinib mesilate, for the: Treatment of myelodysplastic / myeloproliferative diseases

On 23 December 2005, orphan designation (EU/3/05/340) was granted by the European Commission Novartis Europharm Limited, United Kingdom, for imatinib mesilate for the treatment of myelodysplastic / myeloproliferative diseases. Please note that this product...

Europe - EMA - European Medicines Agency

24-7-2015

Pending EC decision: Praluent, alirocumab, Opinion date: 23-Jul-2015

Europe - EMA - European Medicines Agency

24-7-2015

Pending EC decision: Intuniv, guanfacine, Opinion date: 23-Jul-2015

Europe - EMA - European Medicines Agency

24-7-2015

Pending EC decision: Ivabradine Anpharm, ivabradine, Opinion date: 23-Jul-2015

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2015

Ten new medicines recommended for authorisation in the EU, and first malaria vaccine receives positive scientific opinion for use outside the EU...

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: First malaria vaccine receives positive scientific opinion from EMA

Mosquirix to be used for vaccination of young children, together with established antimalarial interventions...

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: Praluent recommended for approval to lower cholesterol

Medicine to offer therapy for patients unable to control high cholesterol with currently available treatment...

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: EMA recommends approval of treatment for attention deficit hyperactivity disorder

Intuniv to be used in combination with comprehensive behavioural treatment in children and adolescents...

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: EMA to review Inductos

The European Medicines Agency (EMA) has started a review of Inductos, an implant used in patients with spinal disc problems and leg fractures....

Europe - EMA - European Medicines Agency

24-7-2015

REMEDY BARRIER CREAM CLOTHS (Dimethicone) Cloth [Medline Industries, Inc.]

Updated Date: Jul 24, 2015 EST...

US - DailyMed

24-7-2015

PRO-C-DURE 1 KIT (Marcaine, Lidocaine, Kenalog, Povidone Iodine) Kit [Oaklock, LLC]

Updated Date: Jul 24, 2015 EST...

US - DailyMed

24-7-2015

DG HEALTH ALLERGY (Diphenhydramine Hydrochloride) Tablet [Dolgencorp, LLC]

Updated Date: Jul 24, 2015 EST...

US - DailyMed

24-7-2015

LIVIXIL PAK (Lidocaine 2.5% And Prilocaine 2.5%) Kit [Alvix Laboratories, LLC]

Updated Date: Jul 24, 2015 EST...

US - DailyMed

24-7-2015

EASTER SCALP (Pyrithione Zinc) Solution [WECOSMETICS Co.]

Updated Date: Jul 24, 2015 EST...

US - DailyMed